Superstring Capital Management’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Sell
155,813
-120,005
-44% -$2.37M 1.87% 20
2026
Q1
$5.19M Buy
275,818
+78,965
+40% +$1.46M 3.71% 12
2025
Q4
$3.47M Sell
196,853
-3,775
-2% -$88.4K 1.86% 19
2025
Q3
$6.8M Buy
200,628
+65,733
+49% +$2.26M 6.7% 1
2025
Q2
$4.72M Sell
134,895
-160,052
-54% -$5.26M 5.59% 6
2025
Q1
$10.7M Sell
294,947
-108,683
-27% -$3.34M 12.68% 1
2024
Q4
$10.6M Sell
403,630
-223,302
-36% -$6.2M 9.15% 3
2024
Q3
$15.1M Buy
626,932
+411,754
+191% +$7.78M 13.25% 1
2024
Q2
$3.73M Buy
+215,178
New +$3.78M 4.7% 7

Other funds holding ZLAB

Superstring Capital Management's ZLAB Position: Q2 2026 in Review

Superstring Capital Management reduced its Zai Lab (ZLAB) stake by 44% in Q2 2026, selling an estimated $2.37M and leaving 155,813 shares worth $2.96M. The position accounts for 1.87% of the portfolio, ranked #20.

Superstring Capital Management first reported a position in ZLAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.1M in Q3 2024. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Superstring Capital Management held 155,813 shares of Zai Lab worth $2.96M as of Q2 2026.
  • Superstring Capital Management sold 120,005 Zai Lab shares in Q2 2026, an estimated $2.37M.
  • Zai Lab made up 1.87% of Superstring Capital Management's portfolio in Q2 2026, its #20 holding.
  • Superstring Capital Management first reported a position in Zai Lab in Q2 2024 and has held it in 9 quarters since.
  • Superstring Capital Management's Zai Lab position peaked at $15.1M in Q3 2024.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.